LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 28 of 483
Next
>>
>
676 to 700 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	WZ3105	0.12	uM	LJP5	1	D23	72	hr	1334	1016	3970	0.2559	-0.1209
BT-20	WZ3105	0.12	uM	LJP5	2	D23	72	hr	1334	1122	3970	0.2826	-0.0807
BT-20	WZ3105	0.12	uM	LJP5	3	D23	72	hr	1334	1216	3970	0.3062	-0.0450
BT-20	XMD11-50	0.12	uM	LJP6	1	P11	72	hr	1334	4258	3970	1.0723	1.1089
BT-20	XMD11-50	0.12	uM	LJP6	2	P11	72	hr	1334	4013	3970	1.0106	1.0160
BT-20	XMD11-50	0.12	uM	LJP6	3	P11	72	hr	1334	3421	3970	0.8615	0.7914
BT-20	Y39983	0.12	uM	LJP6	1	P05	72	hr	1334	4531	3970	1.1410	1.2125
BT-20	Y39983	0.12	uM	LJP6	2	P05	72	hr	1334	4200	3970	1.0577	1.0869
BT-20	Y39983	0.12	uM	LJP6	3	P05	72	hr	1334	4166	3970	1.0491	1.0740
BT-20	YM 201636	0.12	uM	LJP5	1	N11	72	hr	1334	4049	3970	1.0197	1.0296
BT-20	YM 201636	0.12	uM	LJP5	2	N11	72	hr	1334	4167	3970	1.0494	1.0744
BT-20	YM 201636	0.12	uM	LJP5	3	N11	72	hr	1334	4215	3970	1.0615	1.0926
BT-20	ZSTK474	0.12	uM	LJP6	1	M17	72	hr	1334	4099	3970	1.0323	1.0486
BT-20	ZSTK474	0.12	uM	LJP6	2	M17	72	hr	1334	3840	3970	0.9670	0.9503
BT-20	ZSTK474	0.12	uM	LJP6	3	M17	72	hr	1334	3814	3970	0.9605	0.9405
BT-20	Afatinib	0.37	uM	LJP6	1	G22	72	hr	1334	3249	3970	0.8182	0.7262
BT-20	Afatinib	0.37	uM	LJP6	2	G22	72	hr	1334	3504	3970	0.8824	0.8229
BT-20	Afatinib	0.37	uM	LJP6	3	G22	72	hr	1334	3162	3970	0.7963	0.6932
BT-20	Sigma A6730	0.37	uM	LJP5	1	B22	72	hr	1334	3692	3970	0.9298	0.8942
BT-20	Sigma A6730	0.37	uM	LJP5	2	B22	72	hr	1334	3856	3970	0.9711	0.9564
BT-20	Sigma A6730	0.37	uM	LJP5	3	B22	72	hr	1334	4040	3970	1.0174	1.0262
BT-20	Alvocidib	0.37	uM	LJP6	1	A16	72	hr	1334	764	3970	0.1924	-0.2165
BT-20	Alvocidib	0.37	uM	LJP6	2	A16	72	hr	1334	774	3970	0.1949	-0.2127
BT-20	Alvocidib	0.37	uM	LJP6	3	A16	72	hr	1334	700	3970	0.1763	-0.2408
BT-20	AT-7519	0.37	uM	LJP6	1	K04	72	hr	1334	3006	3970	0.7570	0.6340

|<
<<
Previous
Page 28 of 483
Next
>>
>
676 to 700 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)